YTHDF2调节自我非编码RNA代谢,以控制炎症和瘤发生
Seungwon Yang1, Yan-Hong Cui2, Haixia Li2
1Department of Medicine, Section of Dermatology, University of Chicago, Chicago, IL, USA. syang80research@gmail.com.
Nature communications
|November 12, 2025
概括
YTHDF2识别了m6A甲基化U6snRNA,降低了它的稳定性并阻止了Toll-like受体3 (TLR3) 的激活. 这种机制抑制炎症和瘤发生,突出显示YTHDF2和m6A U6作为治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 在RNA生物学,RNA生物学.
背景情况:
- 在自我非编码RNA中m6ARNA甲基化的功能在很大程度上是未知的.
- 收费类受体3 (TLR3) 在炎症反应中起作用.
研究的目的:
- 研究m6A甲基化U6小核RNA (snRNA) 在调节炎症反应中的作用.
- 阐明YTH域含有家族蛋白2 (YTHDF2) 与U6 snRNA和TLR3.3相互作用的机制.
主要方法:
- 利用了人类和小鼠的细胞系和小鼠模型.
- 使用分子生物学技术研究了U6 snRNA,YTHDF2和TLR3之间的相互作用.
- 研究了UVB暴露对YTHDF2活动的影响.
- 评估了Ythdf2删除对小鼠炎症反应和瘤启动的影响.
主要成果:
- 甲基化U6 snRNA被YTHDF2识别,这降低了U6 snRNA的稳定性,并阻止其与TLR3结合.
- U6 snRNA通过结合内基因中TLR3的LRR21域来激活炎症基因表达.
- 通过SIDT2局部化到内分体的YTHDF2,抑制了U6-TLR3相互作用.
- 紫外线暴露降低了YTHDF2,增强了炎症反应,并在没有皮肤的小鼠中促进了瘤开始Ythdf2.
结论:
- YTHDF2通过抑制m6A U6介导的TLR3激活来控制炎症至关重要.
- YTHDF2和m6A U6代表了炎症和瘤发生的潜在治疗点.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Inflammatory Response
15.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.9K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
Regulation of the Unfolded Protein Response
2.9K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
Riboswitches
9.5K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
9.5K


